TriOar Inc.

📍 Daejeon, South Korea🗓 Founded 2021👥 4 employees💰 Last funded Jun 2025
Biotechnology Research🌐 trioar.co.kr
Website LinkedIn
At TriOar, our mission is to transform the future of antibody-based therapeutics. Led by a team of highly experienced scientists in the field, our work centers around developing next-generation antibody-drug conjugate (ADC) and immuno-oncology (IO) technologies to solve one of the biggest challenges in oncology: expanding the therapeutic index so that more patients can benefit from novel cancer therapies worldwide. If you share our passion for advancing oncology innovation, let’s connect and explore what we can achieve together.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
South Korea
1
Frequently asked questions
Who invested in TriOar Inc.?
TriOar Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did TriOar Inc. last raise funding?
The most recent investment in TriOar Inc. recorded on gritt.io was in June 2025.
When was TriOar Inc. founded?
TriOar Inc. was founded in 2021.
What industry is TriOar Inc. in?
TriOar Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is TriOar Inc. based?
TriOar Inc. is headquartered in Daejeon, South Korea.